NHS alert over 'lifelong' issue affecting the brain and spine
Around 150,000 people are living with the condition in the UK, while a further 7,100 are newly diagnosed each year
The NHS has highlighted the possible symptoms of an incurable health issue that dramatically impacts the central nervous system. While it can affect anyone at any age, the condition is more common among people between 20 and 50 years old.
Posting to X this morning, the health service said: "Today is #WorldMSDay. Multiple sclerosis (MS) is a lifelong condition which can affect the brain and spinal cord. There are lots of possible symptoms of MS and everyone with the condition is affected differently."
More than 150,000 people are living with MS in the UK, while almost 7,100 are newly diagnosed each year, according to the MS Society 's estimates. The condition arises when the immune system attacks the brain and nerves, though the exact triggers remain largely unknown.
Possible symptoms of MS can include:
Extreme tiredness/fatigue
Memory and concentration issues
Sexual problems, including a dry vagina or erection problems
Blurred vision, eye pain and other sight issues
Needing to pee more frequently or losing control over urination
Feeling off balance, dizzy or clumsy
Numbness or tingling in different parts of the body
Muscle cramps, spasms and stiffness
There are three main types of MS, and symptoms can vary significantly from person to person. For instance, the first primary type of MS, 'relapse-remitting', describes fluctuating symptoms with different degrees of severity over time.
However, this often gradually develops into 'secondary progressive' MS, where symptoms become constant and also steadily worsen. Meanwhile, 'primary progressive' is a less common type of MS in which a person only experiences worsening symptoms from the onset, rather than having the initial 'relapsing-remitting' stage.
READ MORE: Davina McCall says 'horrible' ordeal felt like 'Alzheimer's' after brain surgery
If you suspect you have symptoms of MS, it's important to seek GP advice. There is no single tool to diagnose the condition, but a medical professional may conduct MRI scans, blood tests, and take spinal fluid samples to better understand your problem.
NHS guidance explains: "There is currently no cure for multiple sclerosis (MS). But there are treatments that can slow the progression of MS and help ease symptoms.
"The type of treatment will depend on the type of MS you have and your symptoms. You'll probably need different treatments over time. You'll be supported by different healthcare professionals.
"This may include a specialist MS nurse, a neurologist (brain and nerve specialist), physiotherapist and occupational therapist." Despite this advice, anyone who suddenly experiences balance issues, weakness or numbness in one arm, or blurred vision is urged to call 999.
These may be signs of a stroke - a medical emergency that requires immediate attention.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South Wales Argus
an hour ago
- South Wales Argus
More than 1,000 patients spent longer than 12 hours in A&E
The figures were released by Aneurin Bevan University Health Board (ABUHB) and fall "well short" of the Welsh Government's target of zero. The latest statistics also revealed that seven per cent of patients waited more than 12 hours in A&E. A spokesperson for the health board said the area had some of the lowest percentage of patients with long waits to be seen in an Emergency Department across Wales. But the figures were criticised by Senedd member for Monmouth, Peter Fox. He said: "Once again, these statistics make for some very grim reading. "We continue to read of stories from patients who have poor experiences in our hospitals, and my inbox is full of the same. "I have always said, and will continue to advocate, that this is not the fault of our outstanding doctors, nurses and healthcare professionals. "They go above and beyond to provide for our residents. They are being let down by those in charge. "The Welsh Labour Government must get a grip of their systemic failure." Last autumn Wales First Minister Eluned Morgan said she wanted the number of people waiting for more than two years from referral to treatment to be reduced to "around" 8,000 by the spring, and recent figures show that target was broadly met. The statistics also revealed that NHS waiting lists remained at 790,020 pathways across Wales, which is the equivalent of nearly one in four people in Wales. The number of patient pathways decreased from 793,900 in February to 790,020 in March. A pathway represents a wait for treatment, so one patient can be on more than one pathway, for example if they have been referred to different departments for different ailments. Though the 'two-year waits' across Wales have fallen, there remain 269 in the ABUHB area, compared to just 147 across the entirety of England, who have a population of over 57 million. Mr Fox has called on the Welsh Government to urgently address this systemic failure, and to provide the improved service the people of Wales deserve. He added: "Only the Welsh Conservatives have a plan to fix Wales. Labour has broken our Welsh NHS, we will fix it." Wales' health minister Jeremy Miles said: "The latest NHS performance figures show long waiting times are now at their lowest levels since April 2021 and the overall size of the waiting list has fallen for four months in a row. "There are now just under 8,400 people waiting more than two years "I would particularly like to praise Swansea Bay and Hywel Dda university health boards which have joined Powys Health Board in having no patients waiting more than a year for a first outpatient appointment or two years for treatment." A spokesperson for Aneurin Bevan University Health Board said: 'Our staff have worked very hard over recent years to reduce waiting times across all of our services. We continue to see incremental improvement in the number of patients waiting for care. Out of the 25 services we provide; 5 services have zero waits over 52 weeks and only 4 services have patients with waits over 104 weeks. 'The health board continues to report some of the lowest percentage of patients with long waits to be seen in an Emergency Department across Wales. We are actively continuing an improvement programme which includes recent investments in a new Transfer Lounge to support timelier care, an extended Emergency Department waiting room to improve patient experience and reduce waits due to increased assessment space, and additional consultant capacity to ensure rapid senior assessment and treatment. 'Patients on our waiting lists are not just numbers to us; every one of them is an individual whose life is being affected by having to wait. Our staff are continuing to do everything they can to reduce our waiting times and to prioritise the most clinically urgent cases. 'It's important to recognise that these challenges are not unique to any one Health Board; we are currently experiencing these issues right across NHS Wales and in other parts of the UK.'
BBC News
4 hours ago
- BBC News
Pharmacists warn drug shortage affecting cancer patients
Pharmacists have warned that "one of the worst" examples of medicine shortages is affecting cancer a pancreatic enzyme replacement therapy (Pert), helps digestion and is required by patients with pancreatic cancer, cystic fibrosis, and chronic pancreatitis. It is thought more than 61,000 patients in the UK need the patients are said to be "skipping meals" to ration their medication due to a shortage of it, according to the National Pharmacy Association (NPA).A Department of Health and Social Care spokesperson said there were "European-wide supply issues" and it was "working closely with industry and the NHS" to mitigate the impact on patients. Without the drug, patients lose weight and strength, which means their ability to cope with treatment such as chemotherapy is experts have predicted shortages continuing until next Department of Health and Social Care has extended a serious shortage protocol for Creon which has already been in place for a year. This indicates concern about shortages of a medicine and allows pharmacists to give patients an alternative - though they argue other drugs are also in short supply.A spokesperson for the department said the "European-wide supply issues" were caused by manufacturing supply constraints. 'Extra layer of stress' The National Pharmacy Association said more than three quarters of members covered in a recent survey felt the current arrangements for managing the shortages were inadequate. Some reported that patients were skipping meals and travelling long distances to get hold of the medication, according to the said it was the "worst stock shortage" they had ever had to deal News highlighted the issue in February after a woman got in touch saying it was impossible for her husband, who has pancreatic cancer, to digest his food without Creon. That month, leading pancreatic clinicians and charities wrote to the prime minister, saying the absence of Pert can have a "devastating impact on people's lives".They called for a national strategy to tackle the from Birmingham was diagnosed with pancreatic cancer in 2023 and initially got 15 boxes of Creon capsules every month to help her tolerate chemotherapy. She can now get only six or seven and is having to skip snacks. The 64-year-old said the shortage had profoundly affected her mental health. She told the BBC: "Each day I'm trying to balance: what shall I eat, shall I have a more substantial meal, shall I take my supplements and that creates an extra layer of stress and worry whilst I'm trying to put my life together again after having this diagnosis." 'Taking desperate measures' Alfie Bailey-Bearfield of Pancreatic Cancer UK said the charity had been raising concerns with the government and suppliers for more than a year and it was vital that officials intervened to try to boost supply."Thousands of people affected by pancreatic cancer rely on taking Pert tablets every time they eat simply to digest their food and absorb nutrients – something most of us take for granted," he said."It's totally unacceptable that they are still taking desperate measures which puts their health, wellbeing and their eligibility for treatment at risk," he Leyla Hannbeck, chief executive of the Independent Pharmacies Association said it was very difficult for her members to obtain supplies from the wholesaler."The shortages with Creon has been ongoing for so long and it seems no effective attempts are being made by officials to make the process easier for pharmacies and patients and to put robust plans in place to prioritise the availability of this product," she said."Instead they continue prolonging the current processes."A Department of Health and Social Care spokesperson said it knew "how frustrating and distressing" medicine supply issues can be for patients and clinicians caring for added: "The European-wide supply issues with Creon are caused by a limited availability of raw ingredients and manufacturing capacity constraints."We are working closely with industry and the NHS to mitigate the impact on patients and resolve the issues as quickly as possible."
The Guardian
5 hours ago
- The Guardian
Spending on agency staff across NHS England drops by almost £1bn
Spending on agency staff across NHS England dropped by almost £1bn in the last financial year, ministers have said, after a pledge by Wes Streeting to cut the amount going to agencies by 30%. According to the Department of Health and Social Care, the total spent by trusts on agency staff during 2024-25 was nearly £1bn lower than the previous year. In a speech to the NHS Providers conference in November, Streeting, the health secretary, said a lack of permanent staff had seen gaps filled by more expensive agency-provided replacements totalling about £3bn a year. Under proposals outlined at the time, but not yet enacted, Streeting suggested that NHS trusts could be completely banned from using agency staff for lower level jobs such as healthcare assistants and domestic support workers. This could also involve stopping NHS staff from resigning and then immediately signing on with an agency, so they can do the same work for higher wages, and a much higher overall cost to the NHS. In addition to employing agency staff, which can mean paying a doctor thousand of pounds for a single shift, NHS trusts also routinely plug gaps by using what are known as 'bank' staff – NHS employees who do extra shifts at their own workplace or one nearby, via an organisation usually run by the trust. UK-wide figures reported by the Guardian in January 2024 showed that the combined spend of hospitals and GP surgeries for agency staff was an annual £4.6bn, with another £5.8bn used for bank shifts. As part of the clampdown on agency spending, Streeting and James Mackey, the chief executive of the imminently abolished NHS England, have jointly written to all NHS providers and integrated care board executives to set out that each should target the 30% reduction, and that their progress will be monitored. 'If we do not feel that sufficient progress is being made by the autumn, we will consider what further legislative steps we should take to ensure that use of agency staff is brought to an end,' they wrote. The letter also says hospital bosses should make surethe pay rates for bank shifts 'are competitive but do not exceed those paid by agencies directly to the worker'. Trusts have already been ordered to reduce bank use by at least 10%. Sign up to First Edition Our morning email breaks down the key stories of the day, telling you what's happening and why it matters after newsletter promotion Elizabeth O'Mahony, NHS England's chief financial officer, said: 'The NHS is fully committed to making sure that every penny of taxpayers' money is used wisely to the benefit of patients and the quality of care they receive. 'Our reforms towards driving down agency spend by nearly £1bn over the past year will boost frontline services and help to cut down waiting lists, while ensuring fairness for our permanent staff.'
